Liminatus Pharma, Inc. (LIMN)
Nasdaq: LIMN · CIK 0001971387 · United States
Every official Liminatus Pharma, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open LIMN filings
Liminatus Pharma, Inc. documents
- Liminatus Pharma, Inc. 10-K 2026LIMN 10-K 2026: annual report for fiscal 2026
- Liminatus Pharma, Inc. 10-K 2025LIMN 10-K 2025: annual report for fiscal 2025
- Liminatus Pharma, Inc. 10-K 2024LIMN 10-K 2024: annual report for fiscal 2024
- Liminatus Pharma, Inc. 10-K 2023LIMN 10-K 2023: annual report for fiscal 2023
- Liminatus Pharma, Inc. 10-K 2022LIMN 10-K 2022: annual report for fiscal 2022
- Liminatus Pharma, Inc. 10-Q 2026LIMN 10-Q 2026: quarterly report for fiscal 2026
- Liminatus Pharma, Inc. 10-Q 2025LIMN 10-Q 2025: quarterly report for fiscal 2025
- Liminatus Pharma, Inc. 10-Q 2024LIMN 10-Q 2024: quarterly report for fiscal 2024
- Liminatus Pharma, Inc. 10-Q 2023LIMN 10-Q 2023: quarterly report for fiscal 2023
- Liminatus Pharma, Inc. 10-Q 2022LIMN 10-Q 2022: quarterly report for fiscal 2022
- Liminatus Pharma, Inc. 8-K 2026LIMN 8-K 2026: current report for fiscal 2026
- Liminatus Pharma, Inc. 8-K 2025LIMN 8-K 2025: current report for fiscal 2025
- Liminatus Pharma, Inc. 8-K 2024LIMN 8-K 2024: current report for fiscal 2024
- Liminatus Pharma, Inc. 8-K 2023LIMN 8-K 2023: current report for fiscal 2023
- Liminatus Pharma, Inc. 8-K 2022LIMN 8-K 2022: current report for fiscal 2022
- Liminatus Pharma, Inc. DEF 14A 2026LIMN DEF 14A 2026: proxy statement for fiscal 2026
- Liminatus Pharma, Inc. DEF 14A 2025LIMN DEF 14A 2025: proxy statement for fiscal 2025
- Liminatus Pharma, Inc. DEF 14A 2024LIMN DEF 14A 2024: proxy statement for fiscal 2024
- Liminatus Pharma, Inc. DEF 14A 2023LIMN DEF 14A 2023: proxy statement for fiscal 2023
- Liminatus Pharma, Inc. DEF 14A 2022LIMN DEF 14A 2022: proxy statement for fiscal 2022
- Liminatus Pharma, Inc. Form 4 2026LIMN Form 4 2026: insider trading filing for fiscal 2026
- Liminatus Pharma, Inc. Form 4 2025LIMN Form 4 2025: insider trading filing for fiscal 2025
- Liminatus Pharma, Inc. Form 4 2024LIMN Form 4 2024: insider trading filing for fiscal 2024
- Liminatus Pharma, Inc. Form 4 2023LIMN Form 4 2023: insider trading filing for fiscal 2023
- Liminatus Pharma, Inc. Form 4 2022LIMN Form 4 2022: insider trading filing for fiscal 2022
- Liminatus Pharma, Inc. S-1 2026LIMN S-1 2026: registration statement for fiscal 2026
- Liminatus Pharma, Inc. S-1 2025LIMN S-1 2025: registration statement for fiscal 2025
- Liminatus Pharma, Inc. S-1 2024LIMN S-1 2024: registration statement for fiscal 2024
- Liminatus Pharma, Inc. S-1 2023LIMN S-1 2023: registration statement for fiscal 2023
- Liminatus Pharma, Inc. S-1 2022LIMN S-1 2022: registration statement for fiscal 2022
- Liminatus Pharma, Inc. 13F 2026LIMN 13F 2026: institutional holdings for fiscal 2026
- Liminatus Pharma, Inc. 13F 2025LIMN 13F 2025: institutional holdings for fiscal 2025
- Liminatus Pharma, Inc. 13F 2024LIMN 13F 2024: institutional holdings for fiscal 2024
- Liminatus Pharma, Inc. 13F 2023LIMN 13F 2023: institutional holdings for fiscal 2023
- Liminatus Pharma, Inc. 13F 2022LIMN 13F 2022: institutional holdings for fiscal 2022
More companies